US News

Drugmakers, pharmacies next targets for U.S. opioid settlements

Published by

By Brendan Pierson NEW YORK (Reuters) – With a $26 billion nationwide settlement in sight over claims that the three largest U.S. drug distributors and Johnson & Johnson helped fuel a nationwide opioid epidemic, state and local governments will soon turn their attention to pharmacies and a handful of drugmakers. U.S. state attorneys general are expected to unveil a settlement proposal this week with distributors McKesson Corp, Cardinal Health Inc and AmerisourceBergen Corp contributing a combined $21 billion, while Johnson & Johnson would pay $5 billion. The ultimate settlement price-tag could…

Read More

Facebook Comments

Check Also

CfA Statement on Facebook Ad Targeting Policy Change for Users Under 18

WASHINGTON, D.C. – Today, Facebook Inc (NASDAQ:FB) announced ...